Strategies to eliminate cancer stem cells: clinical implications

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Carol Ann HuffRichard J Jones

Abstract

Over the past two decades, major advances in our understanding of cancer have translated into only modest increments in survival for the majority of cancer patients. Recent data suggesting cancers arise from rare self-renewing stem cells that are biologically distinct from their more numerous differentiated progeny may explain this paradox. Current anticancer therapies have been developed to decrease the bulk of the tumour mass (i.e. the differentiated cancer cells). Although treatments directed against the bulk of the cancer may produce dramatic responses, they are unlikely to result in long-term remissions if the rare cancer stem cells are also not targeted. Conversely, treatments that selectively attack cancer stem cells will not immediately eliminate the differentiated cancer cells, and might therefore be prematurely abandoned if clinical activity is judged solely by traditional response criteria that reflect changes in the bulk of the tumour. Re-examining both our pre-clinical and clinical drug development paradigms to include the cancer stem cell concept has the potential to revolutionize the treatment of many cancers.

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M A KelliherN Rosenberg
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Nov 8, 2001·Blood·F BonifaziUNKNOWN Swedish CML Study Group
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Mar 29, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·A PierceE Spooncer
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
May 21, 2003·Current Urology Reports·Donald Trump, Yiu-Keung Lau
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Nov 25, 2003·Blood·William MatsuiRichard J Jones
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Dec 6, 2003·The Oncologist·Cathie T Chung, Robert W Carlson
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A PileriM Bendandi
Apr 22, 2004·Journal of the National Cancer Institute·Richard J JonesB Douglas Smith
Aug 13, 2004·The New England Journal of Medicine·Catriona H M JamiesonIrving L Weissman
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caio M Rocha LimaLangdon L Miller
Sep 21, 2004·Blood·Jorge CortesHagop Kantarjian
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Nov 3, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R P AbrattS Oudard
Jul 27, 2005·British Journal of Haematology·Greg R AngstreichRichard J Jones
Oct 1, 2003·Journal of the National Comprehensive Cancer Network : JNCCN·UNKNOWN National Comprehensive Cancer Network

❮ Previous
Next ❯

Citations

Jul 4, 2012·Cancer Metastasis Reviews·Darshni ViraEri S Srivatsan
Dec 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher Y ParkIrving L Weissman
Aug 15, 2009·Cell Communication and Signaling : CCS·Thomas SeufferleinGötz von Wichert
Dec 23, 2010·Future Oncology·Hemchandra MahasethChristopher R Flowers
Feb 2, 2008·World Journal of Gastroenterology : WJG·Jing ZhouShan-Miao Gou
Mar 1, 2013·Molecular Cancer Therapeutics·Shuping YinKaladhar B Reddy
Jul 24, 2012·Medical Hypotheses·Deshuai LouYang Cao
May 5, 2012·Cancer Letters·Matthew SmalleyRichard Clarkson
Jan 15, 2011·Cancer Treatment Reviews·M G BourkeG C O'Sullivan
Jan 16, 2010·Experimental Cell Research·Germana Rappa, Aurelio Lorico
Oct 20, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Fu Xue ChenYonghua Ji
Nov 17, 2007·The Veterinary Journal·David J Argyle, Thalia Blacking
Feb 20, 2007·Biochemical and Biophysical Research Communications·Jiri NeuzilStephen J Ralph
Dec 16, 2010·Clinical Lymphoma, Myeloma & Leukemia·Christopher R Flowers, James O Armitage
Feb 1, 2017·Molecular Cancer·Kodappully Sivaraman SiveenRamzi M Mohammad
Jul 1, 2010·Cell Transplantation·Hironobu KawamotoNaoya Kobayashi
Aug 7, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Samuel A WilliamsScott J Dylla
Nov 9, 2016·World Journal of Stem Cells·Maximilian StahlAmer M Zeidan
Oct 14, 2006·Cancer·Axel SchulenburgPeter Valent
Nov 30, 2006·Current Opinion in Oncology·Muhammad Al-Hajj
May 13, 2010·Biological & Pharmaceutical Bulletin·Yongqiang LiaoChao He
Sep 5, 2020·Ecology and Evolution·Brent A ReynoldsMadan K Oli
Jan 23, 2020·Integrative Biology : Quantitative Biosciences From Nano to Macro·Efraín A CermeñoAndrés J García
Nov 30, 2006·Current Opinion in Oncology
Aug 5, 2017·Chemical Reviews·Trevor C Johnson, Dionicio Siegel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Muhammad Al-HajjMichael F Clarke
Journal of Clinical Pharmacology
Vera S Donnenberg, Albert D Donnenberg
Proceedings of the National Academy of Sciences of the United States of America
C Hirschmann-JaxM K Brenner
© 2022 Meta ULC. All rights reserved